What is Repligen Corp (RGEN)?
Repligen Corp is a biopharmaceutical company specializing in the development and manufacture of products used in the production of biologic drugs. The company focuses on technologies and materials that support bioprocessing, including chromatography resins, filtration systems, and single-use technologies. Repligen serves pharmaceutical and biotechnology companies engaged in research, development, and manufacturing of therapeutic proteins and monoclonal antibodies. Its product portfolio includes protein A affinity resins, membrane chromatography, and bioreactor systems. The company emphasizes innovation in bioprocessing to improve efficiency and scalability of biologic drug production. Repligen operates globally, supplying products and services that facilitate the manufacturing of a wide range of biologics. The company maintains collaborations and partnerships within the biopharmaceutical industry to advance its technology offerings. Governance and regulatory compliance are integral to its operations, ensuring adherence to industry standards.
Repligen Corp Stock Price Today: Live Overview
The price today is shaped by ongoing market activity, as Repligen Corp trades at $113.94. The intraday movement spans from $113.57 to $116.66, with a daily change percentage of 0%.
FAQ: Repligen Corp (RGEN)
What is the current price of RGEN stock?
The current price is $113.94.
Does RGEN pay dividends?
Repligen Corp does not pay dividends.
Does RGEN have a formal corporate presence or regional headquarters in the UAE?
Repligen Corp has no official office or subsidiary in the UAE and conducts business through partners and distributors.
What is RGEN best known for?
The company is most famous for its bioprocessing technologies and products.
What assets are typically shown together with RGEN?
Commonly shown alongside RGEN: BioMarin, Sanofi, Amundi MSCI Europe UCITS ETF
Latest shares articles



